Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

IMREG-1

Known as: IMREG 1 
A low molecular weight fraction of human leukocyte dialysates with potential immunostimulatory activity. IMREG-1 is shown to augment and accelerate… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
A general method for the synthesis of dipeptides has been developed, which does not require any coupling reagents. This method is… Expand
2007
2007
This paper deals with the design and implementation of a software system based on Differential Evolution for the registration of… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1995
1995
IMREG-1, a low-molecular-weight immunomodulator derived from normal human leukocyte dialysates, has been shown to enhance… Expand
  • table 1
  • table 2
1991
1991
OBJECTIVE To determine if a 6-month course of therapy with IMREG-1, a leukocyte-derived immunomodulator, slows disease… Expand
1991
1991
  • A. A. Gottlieb
  • International journal of immunopharmacology
  • 1991
  • Corpus ID: 24513522
An immunomodulator, IMREG-1, derived from human leukocyte dialysates exerts a variety of effects on the cell-mediated immune… Expand
1991
1991
IMREG-1, an immunomodulatory biological therapeutic, was studied in a placebo-controlled, double-blind, six-month trial in 45… Expand
1990
1990
The immunologic properties of extracts of human buffy coat leukocytes were initially described by Lawrence in the 1950’s… Expand
1990
1990
Although considerable attention has been devoted to development of antiviral drugs for therapy of HIV infection, relatively… Expand
1988
1988
Human leukocyte dialysates contain substances capable of affecting human immune function. A low molecular weight subfraction… Expand
1986
1986
In previous reports, we have called attention to a group of endogenous immunoamplifiers present in human leukocyte dialysates (1… Expand